News FDA's counsel accused of being too close to drug industry BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7459.189 (Published 22 July 2004) Cite this as: BMJ 2004;329:189 Article Related content Metrics Responses Peer review Related articles News Roundup [abridged Versions Appear In The Paper Journal] US agency wants to limit lawsuits against drug manufacturers Published: 26 January 2006; BMJ 332 doi:10.1136/bmj.332.7535.196-d News Bush plans to screen whole US population for mental illness Published: 17 June 2004; BMJ 328 doi:10.1136/bmj.328.7454.1458 News Scandals have eroded US public's confidence in drug industry Published: 29 July 2004; BMJ 329 doi:10.1136/bmj.329.7460.247 News Extra [these Stories Appear Only On The Web] US bill to shield drug companies from product liability Published: 06 January 2005; BMJ 330 doi:10.1136/bmj.330.7482.62-a See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362
